Facility #1
Cambridge, Cambridgeshire CB21 5EF
0 studies enrolling now · 1 studies all time
What they study most
Alzheimer's Disease
Studies at this site
A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease
— Stopped early